Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Belite Bio stock in Canada

Learn how to buy Belite Bio stock in 5 easy steps.

Belite Bio is a biotechnology business based in the US. Belite Bio stocks (BLTE.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $15.15 – a decrease of 10.99% over the previous week. Belite Bio employs 12 staff and has a market cap (total outstanding stock value) of $314.7 million.

How to buy Belite Bio stock

  1. Choose a stock trading platform. Use our comparison table or choose from our Top Picks below.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds unto your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – BLTE. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Promoted for Beginners

CIBC Investor's Edge


  • Easy to use platform
  • Low fees
  • Student and young investor discounts

Best for Lowest Commissions

Finder Award

Interactive Brokers


  • Access to international stock exchanges
  • Low margin rates
  • Powerful research tools

Promoted for Free Trades

National Bank Direct Brokerage


  • Commission-free trading
  • Several account types available
  • Access to array of research tools

Belite Bio stock price (NASDAQ:BLTE)

Use our graph to track the performance of BLTE stocks over time.

Belite Bio shares at a glance

Information last updated 2022-05-24.
Latest market close$15.15
52-week range$6.00 - $17.50
50-day moving average $13.16
200-day moving average $13.16
Wall St. target priceN/A
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.01

Buy Belite Bio, Inc. stocks from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 5 of 5
Name Product Finder Rating Available Asset Types Stock Trading Fee Account Fee Signup Offer Table description
CIBC Investor's Edge
Finder Rating:
★★★★★
3.8 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs
$4.95–$6.95
$0 if conditions met, or $100
N/A
An easy-to-use platform with access to a variety of tools to help you trade with confidence.
Interactive Brokers
Finder Rating:
★★★★★
4.3 / 5
Stocks, Bonds, Options, ETFs, Currencies, Futures
min $1.00, max 0.5%
$0
N/A
Winner for Best Overall Broker in the Finder Stock Trading Platform Awards.
National Bank Direct Brokerage
Finder Rating:
★★★★★
4.2 / 5
Stocks, Bonds, Options, Mutual Funds, GICs
$0
$0 if conditions met, or $100
Get $0 commission on all transactions with promo code: finder
Questrade
Finder Rating:
★★★★★
4.3 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
$4.95 - $9.95
$0
Get $50 in free trades when you fund your account with a minimum of $1,000.
Opt for self-directed investing and save on fees or get a pre-built portfolio to take out some of the guesswork.
Qtrade Direct Investing
Finder Rating:
★★★★★
3.7 / 5
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Get up to $150 sign-up bonus. Use promo code BONUS150. Conditions apply. Ends June 30, 2023.
Low trading commissions and an easy-to-use platform with access to powerful tools and a wide selection of investment options.
loading

Is it a good time to buy Belite Bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Belite Bio price performance over time

Historical closes compared with the close of $15.15 from 2023-06-07

1 week (2023-06-01) -10.99%
1 month (2023-05-09) -39.88%
3 months (2023-03-09) -54.24%
6 months (2022-12-09) -51.32%
1 year (2022-06-09) -7.00%
2 years (2021-06-05) N/A
3 years (2020-06-05) N/A
5 years (2018-06-05) N/A
[/expander_content] [/expander]

Belite Bio financials

Gross profit TTM $0
Return on assets TTM -27.78%
Return on equity TTM -46.6%
Profit margin 0%
Book value N/A
Market capitalisation $314.7 million

TTM: trailing 12 months

Belite Bio share dividends

We're not expecting Belite Bio to pay a dividend over the next 12 months.

Belite Bio overview

Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery of vitamin A to the eye to reduce the accumulation of toxic vitamin A by-products in ocular tissue that is in phase 3 clinical trial. The company is also developing LBS-009, an anti-retinol binding protein 4 oral therapy targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, which is in the preclinical development phase. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd. .

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

  • Bad credit loans in Edmonton, Alberta

    From personal and payday loans to lines of credit, compare loans for bad credit in Edmonton.

  • How to buy Sui (SUI) in Canada

    This guide provides step-by-step instructions on how to buy Sui, lists some exchanges where you can get it and provides daily price data on (SUI).

  • How to buy Pepe (PEPE) in Canada

    This guide provides step-by-step instructions on how to buy Pepe, lists some exchanges where you can get it and provides daily price data on (PEPE).

  • How to buy Arbitrum (ARB) in Canada

    This guide provides step-by-step instructions on how to buy Arbitrum, lists some exchanges where you can get it and provides daily price data on (ARB).

  • How to buy SSV Network (SSV) in Canada

    This guide provides step-by-step instructions on how to buy SSV Network, lists some exchanges where you can get it and provides daily price data on (SSV).

  • How to buy USDD (USDD) in Canada

    This guide provides step-by-step instructions on how to buy USDD, lists some exchanges where you can get it and provides daily price data on (USDD).

  • How to buy Blur (BLUR) in Canada

    This guide provides step-by-step instructions on how to buy Blur, lists some exchanges where you can get it and provides daily price data on (BLUR).

  • How to buy FLOKI Inu (FLOKI) in Canada

    This guide provides step-by-step instructions on how to buy FLOKI Inu, lists some exchanges where you can get it and provides daily price data on (FLOKI).

  • How to buy Aptos (APT) in Canada

    This guide provides step-by-step instructions on how to buy Aptos, lists some exchanges where you can get it and provides daily price data on (APT).

  • How to buy EthereumPoW (ETHW) in Canada

    This guide provides step-by-step instructions on how to buy EthereumPoW, lists some exchanges where you can get it and provides daily price data on (ETHW).

Go to site